OTC Foreign Stocks Momentum Watchlist (TBRIF, CGXEF, RQHTF, NILIF)

Many investors employ the strategy of identifying stocks that are gaining momentum as a means to secure profits. These stocks, which experience significant price surges, often maintain their upward trajectory over several trading sessions, offering astute investors opportunities for potential gains.

Now, let’s shift our focus to four OTC F-listed stocks, or foreign-listed companies. This sector may be somewhat underappreciated, but it has the potential to present exciting opportunities for investors that can keep a close eye on the action.

Therma Bright Inc. (OTCQB: TBRIF) (TSXV: THRM) is a dynamic force in the field of cutting-edge medical technology, dedicated to revolutionizing healthcare. With a portfolio that spans diagnostic and medical device technologies, they confront some of the most pressing challenges in today’s medical landscape.

In the realm of Respiratory Health, Therma Bright introduces a game-changer: the Digital Cough Test (DCT) app, a collaboration with AI4LYF. This remarkable app deploys artificial intelligence to discern a myriad of respiratory ailments, including the formidable COVID-19, through the analysis of cough sounds. What sets it apart is its astonishing accuracy, consistently exceeding 94%. Notably, it’s on the cusp of securing the prestigious 513g FDA clearance, a gateway to charging for Remote Therapeutic Monitoring (RTM) and patient reimbursement.

Consumer Health is another sphere where Therma Bright shines. Within this portfolio, three remarkable devices emerge. The Benepod Hot and Cold Contrast Therapy Device emerges as a lifeline for chronic pain sufferers, addressing ailments like osteoarthritis and lower back pain. The InterceptCS takes the spotlight as a pioneering cold sore prevention device. Additionally, the TherOZap offers next-generation pain management relief through thermal therapy for insect bites and stings.

In the arena of Vascular Disease, Therma Bright presents two groundbreaking devices. PREVA stands out as an innovative clot-retrieving marvel, defined by its pioneering distal basket design. Meanwhile, Venowave tackles Deep Vein Thrombosis (DVT), a post-surgery leg pain menace. It’s a compact, lightweight DVT prevention device engineered for both healthcare settings and home use. Its continuous wave motion enhances blood flow, countering venous stasis, a critical contributor to clot formation.

A stark reality surfaces: annual fatalities from blood clot complications surpass those caused by breast cancer, HIV, and traffic accidents combined. This highlights the paramount importance of Deep Vein Thrombosis (DVT) prevention. Notably, over half of DVTs begin forming intra-operatively, with 75% emerging within 48 hours post-operatively. Therma Bright’s technology pioneers a user-friendly, potentially life-saving alternative.

A major stride for the company came in the form of successful U.S. Medicare and Medicaid reimbursement, achieved through a web of payers. Reimbursement for each pair of Venowave devices, under temporary codes, ranged between $725 and $1050 per patient. This development speaks volumes for Therma Bright, streamlining medical billing, and offering clarity and precision for healthcare providers, patients, and insurers. Rob Fia, CEO of Therma Bright, aptly encapsulates its significance.

In sum, Therma Bright Inc. emerges as a beacon of innovation, poised to reshape the healthcare landscape. With a commitment to pioneering technologies that enhance patient outcomes, they are forging a path towards a brighter, healthier future.

CGX Energy Inc. (OTC: CGXEF) is making waves in the oil and gas exploration industry, and its recent stock performance reflects the company’s promising endeavors. On September 1, 2023, CGXEF closed at $0.90 USD per share, marking a significant increase of 16.60% in a single day.

But what’s could be driving this surge in investor interest? Let’s rewind a bit to understand the context.

Earlier this summer, on June 13, 2023, CGX Energy Inc. (TSXV: OYL) announced a pivotal development. The company successfully reached total depth (TD) of 20,450′ on the Wei-1BP1 well, a bypass exploration and appraisal well in the Corentyne block offshore Guyana. This bypass well extended the original Wei-1 wellbore’s depth and penetrated primary Santonian targets. Encouragingly, data collected indicated multiple hydrocarbon shows in the primary target reservoirs. The results were consistent with pre-drill expectations and confirmed the Company’s geologic and geophysical assessment of the block. However, operations required additional funds due to the lost sampling tool and the drilling of the bypass well.

Fast forward to June 28, 2023, and CGX Energy, in partnership with Frontera Energy Corporation, celebrated a significant discovery at the Wei-1 well. They encountered 210 feet of hydrocarbon-bearing sands in the Santonian horizon. Although oil samples were not obtained due to a tool failure, the Joint Venture retrieved wireline logs and extensive core samples for further analysis. The discovery also expanded to the Maastrichtian and the Campanian intervals, with 77 feet of net pay, including indications of light crude in the Campanian and sweet medium crude oil in the Maastrichtian.

More recently, on August 10, 2023, CGX Energy Inc. announced that it had secured funding to cover its share of the additional Wei-1 well costs. Following the successful drilling operations, CGX entered into an agreement with Frontera Energy Corporation. This agreement allows Frontera to farm into the Corentyne block, covering the unexpected additional costs associated with the Wei-1 well. CGX will transfer up to 4.7% of its participating interest in exchange for Frontera’s funding, amounting to approximately $16.5 million. As a result of this agreement, CGX will retain a 27.3% participating interest, while Frontera will hold a 72.7% participating interest in the Corentyne block.

These recent developments demonstrate CGX Energy’s commitment to its exploration efforts in Guyana’s oil and gas sector. The company’s discoveries, coupled with its strategic financial moves, have attracted investor attention, driving a notable increase in its stock price.

In summary, CGX Energy Inc. is riding a wave of success in the oil and gas exploration industry, with promising discoveries and strategic financial arrangements that bode well for its future prospects.

Reliq Health Technologies Inc. (OTC: RQHTF) is making waves in the healthcare technology sector, and its recent stock performance reflects its promising innovations. On September 1, 2023, RQHTF closed at $0.32 USD per share, marking an impressive increase of 16.76%.

This healthcare technology company specializes in developing secure telemedicine and virtual care solutions. One of its standout offerings is the iUGO Care platform, a software-as-a-solution that empowers complex patients to receive care in the comfort of their homes.

A significant recent development is the launch of a post-discharge program tailored for acute care hospitals. Reliq Health Technologies has already inked deals with hospitals in California, Florida, and Puerto Rico, with expectations to add a whopping 5,000 new patients to the platform each month by the end of 2024. This initiative aims to support patients transitioning from acute care hospitals to various care settings, ensuring they receive the right level of care to prevent hospital readmissions.

Notably, under the Centers for Medicare & Medicaid Services (CMS) Hospital Readmissions Reduction Program (HRRP), hospitals failing to meet readmission targets face substantial penalties. Reliq’s iUGO Care platform has demonstrated its ability to reduce readmission rates by over 90%, helping healthcare organizations avoid these financial penalties while improving patient outcomes.

Furthermore, Reliq Health Technologies has signed a significant contract with a respiratory therapy clinic in Texas. This partnership aims to onboard an impressive 10,000 new patients by mid-2024. The iUGO Care platform will provide remote monitoring for patients with conditions like asthma and Chronic Obstructive Pulmonary Disease (COPD). This remote monitoring not only improves patient care but also aligns with the Centers for Medicare & Medicaid Services (CMS) Remote Therapeutic Monitoring (RTM) program, expanding Reliq’s market reach.

Despite challenges such as Hurricane Idalia, the company remains resilient, with sales more than doubling year over year and continued record growth anticipated in the coming years.

Surge Battery Metals Inc. (OTC: NILIF) is making notable strides in the exploration of mineral properties in North America, with a primary focus on lithium and nickel. On September 1, 2023, NILIF closed at $0.59 USD per share, reflecting an impressive 8.61% increase.

A significant recent development for Surge Battery Metals is its upgrade to the OTCQB Venture Market. This upgrade, effective as of August 15, 2023, under the symbol “NILIF,” provides easier access for U.S. institutions and retail investors. The company’s shares will continue to trade on Canada’sTSX Venture Exchange under the symbol “NILI.” This move is anticipated to enhance liquidity and broaden Surge’s shareholder base.

The OTCQB, run by OTC Markets Group Inc., is designed for developing and entrepreneurial companies in the United States and beyond. Companies listed on the OTCQB must maintain current financial reporting and undergo annual verification and management certification processes.

However, an even more recent development is Surge Battery Metals’ engagement of Kautz Environmental Consultants Inc. to address cultural resource impacts at the Nevada North Lithium Project (NNLP). This project involves the preparation of exploration and reclamation plans for the NNLP, with a focus on compliance with the National Historic Preservation Act (NHPA). This legislation requires the project to assess its impacts on cultural resource properties.

Kautz Environmental Consultants will conduct a preliminary review, obtain necessary permits, conduct field investigations, document cultural resources, and evaluate them in accordance with the NHPA. They have extensive experience in similar projects and are well-equipped to meet Surge’s project completion schedule.

Additionally, Surge Battery Metals extended its Media Services Agreement with Life Water Media for three months, totaling US$200,000 in payments. This extension aligns with Surge’s commitment to sustainable development and its dedication to engaging with local cultural communities.

In summary, Surge Battery Metals Inc. is not only advancing its mineral exploration efforts but also demonstrating a commitment to responsible and sustainable development in the field, which could have a positive impact on its stock performance.

Disclaimers:CapitalGainsReport (CGR) is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. CapitalGainsReport (CGR) is owned by RazorPitch Inc. and has been retained by Therma Bright to assist in the production and distribution of content. ‘CGR’ is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by CapitalGainsReport/RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR/RazorPitch is not a fiduciary by virtue of any persons use of or access to this content.